Baxter International | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Abbott USD 49.06B 9.04B 2025-03
AtriCure USD 454.62M 6.35M 2025-03
Avanos Medical USD 839.4M 10.9M 2025-03
Baxter International USD 6.96B 908M 2024-12
Becton, Dickinson and Co. USD 25.24B 36M 2025-03
Boston Scientific USD 22.21B 443M 2025-03
Cooper Companies USD 8.13B 44.1M 2025-01
Dexcom USD 2.27B 164M 2025-03
Edwards Lifesciences USD 10B 452.8M 2024-12
Fresenius EUR 19.41B 135M 2025-03
Globus Medical USD 4.09B 89.26M 2025-03
Halozyme Therapeutics USD 482.27M 118.45M 2025-03
ICU Medical USD 1.99B 22.45M 2025-03
Insulet USD 1.33B 119.1M 2025-03
Integra LifeSciences USD 1.52B 21.14M 2025-03
Intuitive Surgical USD 17.21B 678.1M 2025-03
J&J USD 78.11B 6.62B 2025-03
Laboratory Of America USD 8.32B 269.5M 2025-03
Masimo USD 946.4M 105.5M 2025-03
Medtronic USD 48.02B 1.36B 2025-04
Merit Medical Systems USD 1.43B 49.06M 2025-03
Quest Diagnostics USD 6.93B 151M 2025-03
Smith & Nephew USD 5.26B 60M 2024-12
Stryker USD 20.93B 296M 2025-03
Tandem Diabetes Care USD 155.29M 107.81M 2025-03
Teleflex USD 4.1B 182.98M 2025-03
Terumo JPY 1.37T 35.03B 2025-03
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12



Baxter International Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.